Ciprofloxacin-related acute severe myalgia necessitating emergency care treatment: A case report and review of the literature

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 3, 2009, Pages 165-168

  Eisele, S ^a,c   Garbe, E ^a,b   Zeitz, M ^a   Schneider, T ^a   Somasundaram, Rajan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Ciprofloxacin; Fluoroquinolones; Musculoskeletal pain; Severe myalgia

Indexed keywords

ANALGESIC AGENT; CARBAMAZEPINE; CIPROFLOXACIN; DIAZEPAM; DIPYRONE; FENTANYL; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CHRONIC OTITIS MEDIA; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG WITHDRAWAL; EMERGENCY CARE; HUMAN; MALE; MUSCULOSKELETAL PAIN; MYALGIA; SYSTEMIC THERAPY; TRIGEMINUS NEURALGIA; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; EMERGENCY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MUSCLE DISEASE; OTITIS MEDIA; PAIN; REVIEW;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CIPROFLOXACIN; EMERGENCIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MUSCULAR DISEASES; OTITIS MEDIA; PAIN;

EID: 65549128762     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47165     Document Type: Article

References (25)

1. Assouad M, Willcourt RJ, Goodman PH. Anaphylactoid reactions to ciprofloxacin. Ann Intern Med. 1995; 122: 396-397.
2. Ball P, Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present and future. Drug Saf. 1995; 13: 343-358.
3. Burkhardt O, Kohnlein T, Pap T et al. Recurrent tendinitis after treatment with two different fluoroquinolones. Scand J Infect Dis. 2004; 36: 315-316.
4. Granfors MT, Backman JT, Neuvonen M et al. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism. Clin Pharmacol Ther. 2004; 76: 598-606.
5. Ho DY, Song JC, Wang CC. Anaphylactoid reaction to ciprofloxacin. Ann Pharmacother. 2003; 37: 1018-1023.
6. Hsiao SH, Chang CM, Tsao CJ et al. Acute rhabdomyolysis associated with ofloxacin/levofloxacin therapy. Ann Pharmacother. 2005; 39: 146-149.
7. Kerr BM, Thummel K E, Wurden CJ et al. Human liver carbamazepinemetabolism. Role of CYP3A4 and CYP-2C8 in 10,11-epoxide formation. Biochem Pharmacol. 1994; 47: 1969-1979.
8. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003; 36: 1404-1410.
9. Khaliq Y, Zhanel GG. Musculoskeletal injury associated with fluoroquinolone antibiotics. Clin Plast Surg. 2005; 32: 495-502vi.
10. Levy RH. Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia. 1995; 36 (Suppl. 5): 8-13.
11. Lewis JR, Gums JG, Dickensheets DL. Levofloxacin-induced bilateral Achilles tendonitis. Ann Pharmacother. 1999; 33: 792-795.
12. Makaryus AN, Byrns K, Makaryus MN et al. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? South Med J. 2006; 99: 52-56.
13. Mathis AS, Chan V, Gryszkiewicz M et al. Levofloxacin-associated Achilles tendon rupture. Ann Pharmacother. 2003; 37: 1014-1017.
14. Melhus A. Fluoroquinolones and tendon disorders. Exp Opin Drug Saf. 2005; 4: 299-309.
15. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239-245.
16. Owens RC Jr, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005; 41 (Suppl. 2): S144-S157.
17. Pauwels O. Factors contributing to carbamazepine-macrolide interactions. Pharmacol Res. 2002; 45: 291-298.
18. Pea F, Furlanut M. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions. Clin Pharmacokinet. 2001; 40: 833-868.
19. Petitjeans F, Nadaud J, Perez JP et al. A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin. Eur J Clin Pharmacol. 2003; 59: 779-780.
20. Prabhakar M, Krahn AD. Ciprofloxacin-induced acquired long QT syndrome. Heart Rhythm. 2004; 1: 624-626.
21. Royer RJ. Adverse drug reactions with fluoroquinolones. Therapy. 1996; 51: 414-416.
22. Rubinstein E. History of quinolones and their side effects. Chemotherapy. 2001; 47 (Suppl. 3): 3-48.
23. Schwald N, Debray-Meignan S. Suspected role of ofloxacin in a case of arthralgia, myalgia, and multiple tendinopathy. Rev RhumEngl Ed. 1999; 66: 419-421.
24. Sprandel KA, Rodvold KA. Safety and tolerability of fluoroquinolones. Clin Cornerstone. 2003; (Suppl. 3): S29-S36.
25. T OL, Stewart CE th, Seery L et al. Fluoroquinolone-induced arthralgia and myalgia in the treatment of sinusitis. Am J Rhinol. 2005; 19: 395-399.